Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-005641
Filing Date
2023-02-21
Accepted
2023-02-21 16:02:51
Documents
69
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2367259
2 ex31-1.htm EX-31.1 18103
3 ex31-2.htm EX-31.2 11617
4 ex32-1.htm EX-32.1 11820
  Complete submission text file 0001493152-23-005641.txt   12114852

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ther-20221231.xsd EX-101.SCH 65997
6 XBRL CALCULATION FILE ther-20221231_cal.xml EX-101.CAL 75606
7 XBRL DEFINITION FILE ther-20221231_def.xml EX-101.DEF 370327
8 XBRL LABEL FILE ther-20221231_lab.xml EX-101.LAB 594392
9 XBRL PRESENTATION FILE ther-20221231_pre.xml EX-101.PRE 470325
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 2003303
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 23648011
SIC: 2834 Pharmaceutical Preparations